Cite
HARVARD Citation
Amiot, A. et al. (2022). Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID. Digestive and liver disease. 54 (9), pp. 1162-1167. [Online].